- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-01-0010997

About Aenor Pharmaceuticals Private Limited
Data last updated:
Aenor Pharmaceuticals Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52601HR2020PTC090557. Its GSTIN is 04AAUCA3091Q1Z0 (Chandigarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anurag Mittal and Prabha Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 – A Shiv Pratap Nagar Ambala Cantt Haryana, Haryana, India – 133001.
As per the financials filed for FY 2024, the company reported a revenue of ₹37.39 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹73,031 (net margin 2%) and EBITDA of ₹2.23 Lakh (EBITDA margin 6%).
The company is associated with 1 brand: Aenor Pharmaceuticals. As per MCA filings, the company has open charges of ₹20 Lakh on record.
Aenor Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0010997). For more details, the company can be reached via its website aenorpharmaceuticals.com.
Company details
Recognitions & Rankings of Aenor Pharmaceuticals
Contact details
Aenor Pharmaceuticals Private Limited's registered office is in Ambala, Haryana. Its website is aenorpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address12 – A Shiv Pratap Nagar Ambala Cantt Haryana, Haryana, India – 133001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aenor Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aenor Pharmaceuticals operates one associated brand: Aenor Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributes specialty pharmaceutical drugs to healthcare providers. | aenorpharmaceuticals.com |
Business activity
The main business activity of Aenor Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aenor Pharmaceuticals Private Limited, buy the company report.
Financials of Aenor Pharmaceuticals Private Limited
FY 2025 filings availableAenor Pharmaceuticals Private Limited reported revenue of ₹37.39 Lakh (up 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 15% in the latest year. EBITDA rose 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.23 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹73,031 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6% | |||
| Net Profit Margin | 2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Aenor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aenor Pharmaceuticals Private Limited
Aenor Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Mittal | Director | 30 Oct 2020 | 6 Years 0 Months | Current |
| Prabha Mittal | Director | 30 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Aenor Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pragyan Pharmaceuticals Private Limited | ₹37.48 Lakh (FY 2021) | -28.0% | Kolar, Karnataka, India | |||
| Ovia Pharma Private Limited | ₹37.48 Lakh (FY 2022) | 41.0% | New Delhi, Delhi, India | |||
| Aenor Pharmaceuticals Private Limitedthis company | ₹37.39 Lakh (FY 2024) | ₹73,031 | 2% | 15.0% | Ambala, Haryana, India | |
| Jabh Pharmaceuticals Private Limited | ₹37.25 Lakh (FY 2024) | 36.0% | Delhi, India |
To see the full peer comparison of Aenor Pharmaceuticals Private Limited, buy the company report.
Auditor
Aenor Pharmaceuticals Private Limited is audited by J N S B & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J N S B & CO | FY 2021 | 117177W |
Shareholding
The shareholding of Aenor Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aenor Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Feb 2022 | 100540717 | Others | ₹10 Lakh | Open | |
| 10 Feb 2022 | 100540848 | Others | ₹10 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Aenor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aenor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aenor Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Aenor Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAUCA3091Q1Z0 | Chandigarh | Active | 18 May 2021 |
To see the full GST registrations and return filing status of Aenor Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aenor Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Anurag Mittal was appointed as Director on 30 Oct 2020.
Frequently asked questions
Aenor Pharmaceuticals is an active private limited company based in Ambala, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 October 2020 (6+ years old) and is registered under CIN U52601HR2020PTC090557.
Aenor Pharmaceuticals has 2 current directors:
- Anurag Mittal - Director
- Prabha Mittal - Director
The latest financial statements of Aenor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Aenor Pharmaceuticals is 04AAUCA3091Q1Z0, registered in Chandigarh.
The CIN (Corporate Identification Number) of Aenor Pharmaceuticals is U52601HR2020PTC090557. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aenor Pharmaceuticals was incorporated on 30 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aenor Pharmaceuticals by revenue are Pragyan Pharmaceuticals Private Limited, Ovia Pharma Private Limited, Jabh Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Anurag Mittal was appointed as Director on 30 Oct 2020. Prabha Mittal was appointed as Director on 30 Oct 2020.
Yes, Aenor Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0010997).
Aenor Pharmaceuticals can be reached through the website aenorpharmaceuticals.com. Its registered office is in Ambala, Haryana, India.
The registered office of Aenor Pharmaceuticals is at 12 – A Shiv Pratap Nagar Ambala Cantt Haryana, Haryana, India – 133001.

